Skip to main content
Benjamin Ebert, MD, Oncology, Boston, MA

BenjaminLevineEbertMD

Oncology Boston, MA

Hematologic Oncology

Chair of Medical Oncology, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School

Dr. Ebert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ebert's full profile

Already have an account?

  • Office

    450 Brookline Avenue, Dana 1610A
    Dana-Farber Cancer Institute
    Boston, MA 02115
    Phone+1 617-632-1902

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2001 - 2005
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1999 - 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2004 - 2025

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2011

Publications & Presentations

PubMed

Journal Articles

  • The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor  
    Robert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
  • Defining the Human C2H2 Zinc Finger Degrome Targeted by Thalidomide Analogs Through CRBN  
    Benjamin Ebert, MD, Science Magazine
  • CrbnI391V Is Sufficient to Confer in Vivo Sensitivity to Thalidomide and Its Derivatives in Mice  
    Benjamin L Ebert, Emma C Fink, Blood
  • Join now to see all

Abstracts/Posters

  • Deconstructing the Clonal Advantage and Clonal Stability of 5q- Candidate Genes in Del(5q) MDS on a Single Cell Level
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Burden of Clonal Hematopoiesis in First Responders Exposed to the World Trade Center Disaster
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
    Benjamin L. Ebert, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • When You Least Expect It: Clonal Hematopoiesis as an Incidental Finding 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
  • Friday Scientific Workshop on Myeloid Development 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Optimizing Clinical Outcomes in Blood Cancers Through Groundbreaking Translational Research 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Authored Content

  • The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020

Press Mentions

  • Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy Cancer
    Dana-Farber Cancer Institute Raises More Than $2 Billion in Record-Breaking Fundraising Campaign to Defy CancerSeptember 30th, 2024
  • 5 from HMS Elected to American Academy of Arts and Sciences
    5 from HMS Elected to American Academy of Arts and SciencesMay 4th, 2023
  • Novel Clinical Tool for Clonal Hematopoiesis Identifies High Risk for Clonal Hematopoiesis Patients
    Novel Clinical Tool for Clonal Hematopoiesis Identifies High Risk for Clonal Hematopoiesis PatientsApril 28th, 2023
  • Join now to see all

Grant Support

  • Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2010–2011
  • Novel Treatment Strategies For Sickle Cell DiseaseNational Center For Research Resources2010–2011
  • Identification Of Functional Tumor-Stromal Interactions In The Bone MarrowNational Cancer Institute2009–2010
  • Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2008–2009
  • Functional Genomic Dissection Of Refractory AnemiaNational Heart, Lung, And Blood Institute2008
  • Functional Dissection Of Erythroid DifferentiationNational Heart, Lung, And Blood Institute2005–2007
  • High Throughput Screen For Regulators Of Globin Gene Ex*National Human Genome Research Institute2006
  • High Throughput Screen For Regulators Of GlobinNational Human Genome Research Institute2005